Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03171025
Title Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer (NEXT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Utah
Indications

urethra cancer

bladder carcinoma

ureter carcinoma

Therapies

Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.